Novo Nordisk (NYSE: NVO)
Novo Nordisk Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Novo Nordisk Company Info
Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharm segments. The Diabetes and Obesity Care segment includes insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD), obesity, and other serious chronic diseases. The Biopharm segment focuses on rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.
News & Analysis
Novo Nordisk and Ginkgo Bioworks Are Teaming Up. Here's Why That's Bullish for Both Stocks.
The collaboration could help solve challenges for both businesses.
2 Healthcare Stocks to Buy Hand Over Fist in April
Don't wait too long to invest in these exciting stocks.
Novo Nordisk's Stock Could Get Another Boost, Thanks to This Huge Development
It may not be too late to invest in this promising healthcare stock, even though it may look expensive.
Could This New Development Soon Buoy Eli Lilly and Novo Nordisk Stock?
New findings could lead to more growth from their prized medicines.
After Wegovy's Approval to Treat Heart Disease, Novo Nordisk Continues to Make Moves
Novo Nordisk is off to a red-hot start in 2024, and its latest deal could represent huge potential.
Is Novo Nordisk the Best Healthcare Stock for You?
Novo Nordisk has been a hot buy in recent years, but in the long run, the stock can still go a whole lot higher.
Diversifying Into This Key Market Is 1 More Reason to Buy Novo Nordisk Stock
The semaglutide maker just announced a strategic acquisition that will be a green flag for its future value.
Novo Nordisk and Nvidia Just Partnered on AI. Is the Stock a Buy?
Their joint project is cutting-edge, but it won't pay off immediately.
Valuation
Earnings Transcripts
Novo Nordisk (NVO) Q4 2023 Earnings Call Transcript
NVO earnings call for the period ending December 31, 2023.
Novo Nordisk (NVO) Q3 2023 Earnings Call Transcript
NVO earnings call for the period ending September 30, 2023.
Novo Nordisk (NVO) Q2 2023 Earnings Call Transcript
NVO earnings call for the period ending June 30, 2023.
Novo Nordisk (NVO) Q1 2023 Earnings Call Transcript
NVO earnings call for the period ending March 31, 2023.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.